Hookworm Vaccine Trials Begin at GW

In a pioneering study, infecting healthy adults is the next step toward eradicating the infection. “These past few months have taught me a lot about hookworms, and it’s also given me intriguing insight into my own body and behaviors,” she said. Ms. Markowitz is one of the participants of the Hookworm Study. Check out this article to read more about Ms. Markowitz's experience.

 

Latest News

FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV
Mpox Vaccine Is Safe and Generates a Robust Antibody Response in Adolescents
Latest news about the results of the COVAIL trial regarding the Sanofi booster. GW participated as one of the many sites for this COVID-19 vaccine study.